$5 million public offering of Virios Tereapeutics, Inc.

Represented ThinkEquity, as underwriter, in the $5 million public offering of Virios Therapeutics, Inc., a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia.